Stay updated on Nivolumab Combo Immuno-therapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo Immuno-therapy Clinical Trial page.

Latest updates to the Nivolumab Combo Immuno-therapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's Locations section was updated to add numerous locations across multiple countries and regions and to remove several existing locations, and a Revision: v3.3.3 tag was added.SummaryDifference2%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded 'Results Posted' with detailed safety and efficacy outcome measures, including definitions for dose-limiting toxicities and safety events. Timelines for assessments and links to the Study Protocol and Statistical Analysis Plan were also included.SummaryDifference3%

- Check48 days agoChange DetectedThe revision line now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check55 days agoChange DetectedThe government funding status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedResults status for NCT03377361 changed from 'No Results Posted' to 'Results Submitted'.SummaryDifference0.0%

- Check69 days agoChange DetectedNo significant changes detected on the Study Details page; any observed differences appear non-substantive.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Combo Immuno-therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo Immuno-therapy Clinical Trial page.